Table 5.
Risk Prediction | Diagnosis | Prognosis | Recurrence | |
---|---|---|---|---|
citrate | Mondul et al. 2015 [15] (B) | Kumar et al. 2016 [22]) (B) | Giskeødegård et al. 2013 [52] (T) | |
Huang et al. 2017 [16] (B) | Weis et al. 2017 [65] (O) | Sandsmark et al. 2017 [54] (T) | ||
Roberts et al. 2017 [63] (O) | Nagarajan et al. 2015 [67] (O) | Selnæs et al. 2013 [53] (T) | ||
Wang et al. 2010 [69] (O) | Hansen et al. 2016 [55] (T) | |||
Zhang et al. 2014 [59] (T) | Meller et al. 2016 [57] (T) | |||
Keshari et al. 2011 [58] (T) | ||||
Thysell et al. 2010 [29] (T) | ||||
glycine | de Vogel et al. 2014 [18] | Kumar et al. 2015 [21] (B) | Hansen et al. 2016 [55] | |
Kumar et al. 2016 [22] (B) | ||||
Pérez-Rambla et al. 2017 [37] (U) | ||||
Struck-Lewicka et al. 2015 [38] (U) | ||||
Liu et al. 2015 [46] (T) | ||||
Jung et al. 2013 [47] (T) | ||||
Giskeødegård et al. 2013 [52] (T) | ||||
glycerol-3-phosphate | Andras et al. 2017 [20] (B) | McDunn et al. 2013 [44] (T) | ||
Sreekumar et al. 2009 [28] (T) | Thysell et al. 2010 [29] (T) | |||
glycerophosphocholine | Andras et al. 2017 [20] (B) | Giskeødegård et al. 2013 [52] (T) | ||
Keshari et al. 2011 [58] (T) | ||||
Zhang et al. 2014 [59] (T) | ||||
alanine | Kumar et al. 2015 [21] (B) | Kumar et al. 2015 [21] (B) | ||
Kumar et al. 2016 [22] (B) | Zhang et al. 2014 [59] (T) | |||
Struck-Lewicka et al. 2015 [38] (U) | ||||
Shuster et al. 2011 [45] (T) | ||||
Jung et al. 2013 [47] (T) | ||||
Zhang et al. 2014 [59] (T) | ||||
choline | Ren et al. 2016 [43] | Selnæs et al. 2013 [53] (T) | ||
Shuster et al. 2011 [45] | Zhang et al. 2014 [59] (T) | |||
Giskeødegård et al. 2013 [52] (T) | Nagarajan et al. 2015 [67] (O) | |||
Keshari et al. 2011 [58] (T) | Kobuscet al. 2011 [68] (O) | |||
Zhang et al. 2014 [59] (T) | ||||
Weis et al. 2017 [65] (O) | ||||
Wang et al. 2010 [69] (O) | ||||
phosphocholine | Giskeødegård et al. 2013 [52] (T) | Zhang et al. 2014 [59] (T) | ||
Keshari et al. 2011 [58] (T) | ||||
Zhang et al. 2014 [59] (T) | ||||
glycerophosphocholine | Andras et al. 2017 [20] (B) | Zhang et al. 2014 [59] (T) | ||
Giskeødegård et al. 2013 [52] (T) | ||||
Keshari et al. 2011 [58] (T) | ||||
uracil | Huan et al. 2016 [42] (T) | |||
Sreekumar et al. 2009 [28] (T) | ||||
Shuster et al. 2011 [45] (T) | ||||
Jung et al. 2013 [47] (T) | ||||
McDunn et al. 2013 [44] (T) | ||||
proline | Dereziński et al. 2017 [27] (B) | Sreekumar et al. 2009 [28] (T) | ||
Jung et al. 2013 [47] (T) | Liu et al. 2015 [46] (T) | |||
McDunn et al. 2013 [44] (T) | ||||
histidine | Fernández-Peralbo et al. 2016 [35] (U) | |||
Jung et al. 2013 [47] (T) | ||||
spermine | Roberts et al. 2017 [63] (O) | Nagarajan et al. 2015 (O) | Liu et al. 2015 [46] (T) | |
Weis et al. 2017 [65] (O) | Shuster et al. 2011 [45] (T) | |||
Giskeødegård et al. 2013 [52] (T) | ||||
Selnæs et al. 2013 [53] (T) | ||||
Sandsmark et al. 2017 [54] (T) | ||||
Hansen et al. 2016 [55] (T) | ||||
Meller et al. 2016 [57] (T) | ||||
Maxeiner et al. 2010 [ 60] (T) | ||||
2-aminoadipic acid | Jung et al. 2013 [47] (T) | |||
Shuster et al. 2011 [45] (T) | ||||
Sreekumar et al. 2009 [28] (T) | ||||
Priolo et al. 2014 [48] (T) |
B: Blood, U: Urine, T: Tissue, O: Other.